{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:20:12Z","timestamp":1770888012669,"version":"3.50.1"},"reference-count":43,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"King Hussein Cancer Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Midline gliomas are tumors that occur in midline structures and can be circumscribed or diffuse. Classical midline structures include the thalamus, brainstem, and spinal cord. Other midline structures include the corpus callosum, basal ganglia, ventricles, paraventricular structures, and cerebellum. Diffuse midline glioma (DMG) is a diffuse glioma that occurs in the classical midline structures, characterized by a specific genetic alteration, and associated with grim outcome. This study was conducted at King Hussein Cancer Center and reviewed the medical records of 104 patients with circumscribed and diffuse gliomas involving midline structures that underwent biopsy between 2005 and 2022. We included a final cohort of 104 patients characterized by a median age of 23 years and a male-to-female ratio of 1.59-to-1. Diffuse high-grade glioma (DHGG) was the most common pathological variant (41.4%), followed by DMG (28.9%). GFAP was positive in most cases (71.2%). Common positive mutations\/alterations detected by surrogate immunostains included H3 K27me3 (28.9%), p53 (25.0%), and H3 K27M (20.2%). Age group, type of treatment, and immunohistochemistry were significantly associated with both the location of the tumor and tumor variant (all; p &lt; 0.05). DMGs were predominantly found in the thalamus, whereas circumscribed gliomas were most commonly observed in the spinal cord. None of the diffuse gliomas outside the classical location, or circumscribed gliomas harbored the defining DMG mutations. The median overall survival (OS) for the entire cohort was 10.6 months. Only the tumor variant (i.e., circumscribed gliomas) and radiotherapy were independent prognosticators on multivariate analysis.<\/jats:p>","DOI":"10.3390\/cancers15184545","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T10:00:23Z","timestamp":1694685623000},"page":"4545","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Midline Gliomas: A Retrospective Study from a Cancer Center in the Middle East"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8004-0963","authenticated-orcid":false,"given":"Sarah","family":"Al Sharie","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Yarmouk University, Irbid 21163, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dima","family":"Abu Laban","sequence":"additional","affiliation":[{"name":"Department of Radiology, King Hussein Cancer Center, Amman 11941, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamil","family":"Nazzal","sequence":"additional","affiliation":[{"name":"Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman 11941, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0826-4954","authenticated-orcid":false,"given":"Shahad","family":"Iqneibi","sequence":"additional","affiliation":[{"name":"Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman 11941, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sura","family":"Ghnaimat","sequence":"additional","affiliation":[{"name":"Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman 11941, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3517-3601","authenticated-orcid":false,"given":"Abdallah","family":"Al-Ani","sequence":"additional","affiliation":[{"name":"Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman 11941, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6392-150X","authenticated-orcid":false,"given":"Maysa","family":"Al-Hussaini","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman 11941, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"153483","DOI":"10.1016\/j.prp.2021.153483","article-title":"Simplified approach for pathological diagnosis of diffuse gliomas in adult patients","volume":"223","author":"Santisukwongchote","year":"2021","journal-title":"Pathol. Res. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00401-018-1826-y","article-title":"cIMPACT-NOW update 2: Diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma\/anaplastic astrocytoma, IDH-mutant","volume":"135","author":"Louis","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","article-title":"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations","volume":"46","author":"Buczkowicz","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"14377","DOI":"10.1038\/s41598-021-92943-0","article-title":"Topographic correlates of driver mutations and endogenous gene expression in pediatric diffuse midline gliomas and hemispheric high-grade gliomas","volume":"11","author":"Kazarian","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/bpa.12336","article-title":"Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations","volume":"26","author":"Solomon","year":"2016","journal-title":"Brain Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/bpa.12042","article-title":"Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas","volume":"23","author":"Venneti","year":"2013","journal-title":"Brain Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncology"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Di Ruscio, V., Del Baldo, G., Fabozzi, F., Vinci, M., Cacchione, A., de Billy, E., Megaro, G., Carai, A., and Mastronuzzi, A. (2022). Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle. Diagnostics, 12.","DOI":"10.3390\/diagnostics12092064"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Argersinger, D.P., Rivas, S.R., Shah, A.H., Jackson, S., and Heiss, J.D. (2021). New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of H3K27M-Mutant Diffuse Midline Glioma. Cancers, 13.","DOI":"10.3390\/cancers13215280"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11060-022-04024-5","article-title":"Adult diffuse midline gliomas H3 K27-altered: Review of a redefined entity","volume":"158","author":"Navarro","year":"2022","journal-title":"J. Neurooncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"103453","DOI":"10.1016\/j.ebiom.2021.103453","article-title":"Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma","volume":"69","author":"Price","year":"2021","journal-title":"eBioMedicine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/jnen\/nlac016","article-title":"Beyond Midline: Diffuse Hemispheric Glioma, H3 K27M-Mutant with Aggressive Behavior","volume":"81","author":"Carraro","year":"2022","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_14","unstructured":"Amit, A., and Luis Rafael, M.-S. (2018). Brain Tumors, IntechOpen. Chapter 2."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/neuonc\/noaa249","article-title":"Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-na\u00efve diffuse midline glioma models","volume":"23","author":"Vitanza","year":"2021","journal-title":"Neuro-oncology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00401-018-1805-3","article-title":"Circumscribed\/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas","volume":"135","author":"Pratt","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.21037\/qims-22-339","article-title":"A rare presentation of primary lateral ventricle H3 K27-altered diffuse midline glioma in a 14-year-old girl: A case description","volume":"12","author":"Zhao","year":"2022","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.hemonc.2015.02.001","article-title":"Cancer care in Jordan","volume":"8","author":"Attiga","year":"2015","journal-title":"Hematol. Oncol. Stem Cell Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011\u20132015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro-Oncology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","article-title":"Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries","volume":"36","author":"Hoffman","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e2086","DOI":"10.1212\/WNL.0000000000005658","article-title":"FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas","volume":"90","author":"Picca","year":"2018","journal-title":"Neurology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocn.2020.10.005","article-title":"Adult diffuse midline gliomas: Clinical, radiological, and genetic characteristics","volume":"82","author":"Dono","year":"2020","journal-title":"J. Clin. Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11060-019-03134-x","article-title":"Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas","volume":"143","author":"Schreck","year":"2019","journal-title":"J. Neuro-Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/neuonc\/nox107","article-title":"Contemporary survival endpoints: An International Diffuse Intrinsic Pontine Glioma Registry study","volume":"19","author":"Cooney","year":"2017","journal-title":"Neuro Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/1570159X14666160509123229","article-title":"Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets","volume":"15","author":"Johung","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s40478-018-0614-1","article-title":"Transcriptomic and epigenetic profiling of \u2018diffuse midline gliomas, H3 K27M-mutant\u2019 discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location","volume":"6","author":"Castel","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/PAS.0000000000001897","article-title":"Diffuse Midline Gliomas with Histone H3 K27M Mutation in Adults and Children: A Retrospective Series of 164 Cases","volume":"46","author":"Zheng","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_28","first-page":"vdab135","article-title":"H3K27M-mutant, hemispheric diffuse glioma in an adult patient with prolonged survival","volume":"3","author":"Chia","year":"2021","journal-title":"Neurooncol. Adv."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"602553","DOI":"10.3389\/fonc.2020.602553","article-title":"Clinical Features and Molecular Markers on Diffuse Midline Gliomas with H3K27M Mutations: A 43 Cases Retrospective Cohort Study","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/nan.12196","article-title":"Evidence for BRAF V600E and H3F3A K27M double mutations in paediatric glial and glioneuronal tumours","volume":"41","author":"Nguyen","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40478-016-0361-0","article-title":"Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation","volume":"4","author":"Orillac","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/acn3.184","article-title":"Long survival in a child with a mutated K27M-H3.3 pilocytic astrocytoma","volume":"2","author":"Hochart","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5414\/NP301085","article-title":"H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis","volume":"37","year":"2018","journal-title":"Clin. Neuropathol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Li, Z., Li, H., Tan, J., Lai, M., Chen, W., Liu, M., Zhou, Z., Deng, D., Cheng, B., and Fan, C. (2022). The Biological Behavior of High-Grade Glioma in H3K27M Mutant Circumscribed Midline Gliomas, Research Square.","DOI":"10.21203\/rs.3.rs-1184553\/v2"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3389\/fphar.2017.00495","article-title":"Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma","volume":"8","author":"Long","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11864-001-0074-9","article-title":"Pediatric glial tumors","volume":"2","author":"Cohen","year":"2001","journal-title":"Curr. Treat. Opt. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s13311-017-0514-2","article-title":"Targeting Epigenetic Pathways in the Treatment of Pediatric Diffuse (High Grade) Gliomas","volume":"14","author":"Vanan","year":"2017","journal-title":"Neurotherapeutics"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nm.4293","article-title":"EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas","volume":"23","author":"Mohammad","year":"2017","journal-title":"Nat. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2124058","DOI":"10.1080\/2162402X.2022.2124058","article-title":"Immunotherapy approaches for the treatment of diffuse midline gliomas","volume":"11","author":"Bernstock","year":"2022","journal-title":"Oncoimmunology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"100899","DOI":"10.1016\/j.neo.2023.100899","article-title":"Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas","volume":"40","author":"Noon","year":"2023","journal-title":"Neoplasia"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neo.2020.09.005","article-title":"ONC201 and imipridones: Anti-cancer compounds with clinical efficacy","volume":"22","author":"Prabhu","year":"2020","journal-title":"Neoplasia"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"693145","DOI":"10.3389\/fped.2021.693145","article-title":"A Novel Therapeutic Mechanism of Imipridones ONC201\/ONC206 in MYCN-Amplified Neuroblastoma Cells via Differential Expression of Tumorigenic Proteins","volume":"9","author":"Hanna","year":"2021","journal-title":"Front. Pediatr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejca.2022.10.014","article-title":"Real-time drug testing of paediatric diffuse midline glioma to support clinical decision making: The Zurich DIPG\/DMG centre experience","volume":"178","author":"Mueller","year":"2023","journal-title":"Eur. J. Cancer"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/18\/4545\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:50:16Z","timestamp":1760129416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/18\/4545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,13]]},"references-count":43,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["cancers15184545"],"URL":"https:\/\/doi.org\/10.3390\/cancers15184545","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,13]]}}}